Enarodustat is a small molecule hypoxia-inducible factor prolyl hydroxylase inhibitor used as an oral erythropoiesis-stimulating agent for the treatment of anemia associated with chronic kidney disease.… Read more











Enarodustat is a small molecule hypoxia-inducible factor prolyl hydroxylase inhibitor used as an oral erythropoiesis-stimulating agent for the treatment of anemia associated with chronic kidney disease. This category provides essential reference standards for Enarodustat, enabling comprehensive analytical testing, method validation, and quality control processes. Laboratories utilize these high-quality materials, including identified pharmacopeial and non-pharmacopeial impurities, to conduct accurate impurity profiling and quantitation. The collection also features stable isotope-labeled compounds, such as deuterium-labeled analogs, which serve as critical internal standards for mass spectrometry-based bioanalytical assays. By offering access to relevant metabolites and degradation products, including N-nitroso derivatives and other process-related impurities, this selection supports pharmaceutical research and regulatory compliance in the development and manufacturing of this therapeutic agent.